131 related articles for article (PubMed ID: 16444448)
1. Sustained response to anti-CD20 monoclonal antibody in severe acute primary immune thrombocytopenic purpura: report of one adult case.
Luzzatto G; Cella G; Fabris F
Clin Appl Thromb Hemost; 2006 Jan; 12(1):120-1. PubMed ID: 16444448
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
Gómez-Almaguer D
Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
[TBL] [Abstract][Full Text] [Related]
3. Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura.
Bengtson KL; Skinner MA; Ware RE
J Pediatr; 2003 Nov; 143(5):670-3. PubMed ID: 14615744
[TBL] [Abstract][Full Text] [Related]
4. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
Stasi R; Pagano A; Stipa E; Amadori S
Blood; 2001 Aug; 98(4):952-7. PubMed ID: 11493438
[TBL] [Abstract][Full Text] [Related]
5. [Rituximab treatment for adults with steroid-resistant idiopathic thrombocytopenic purpura].
Wang W; Yu QH; Zhang HY; Chu XX; Chen F; Zhang CQ; Zhou YH; Hou M
Zhonghua Nei Ke Za Zhi; 2008 Mar; 47(3):225-7. PubMed ID: 18785508
[TBL] [Abstract][Full Text] [Related]
6. Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia.
Faurschou M; Hasselbalch HC; Nielsen OJ
Eur J Haematol; 2001 Jun; 66(6):408-11. PubMed ID: 11488941
[TBL] [Abstract][Full Text] [Related]
7. Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action.
Pescovitz MD
Am J Transplant; 2006 May; 6(5 Pt 1):859-66. PubMed ID: 16611321
[TBL] [Abstract][Full Text] [Related]
8. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus.
ten Cate R; Smiers FJ; Bredius RG; Lankester AC; van Suijlekom-Smit LW; Huizinga TW; Egeler RM
Rheumatology (Oxford); 2004 Feb; 43(2):244. PubMed ID: 14739467
[No Abstract] [Full Text] [Related]
10. Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab.
El-Shanawany TM; Williams PE; Jolles S
J Clin Pathol; 2007 Jun; 60(6):715-6. PubMed ID: 17483248
[No Abstract] [Full Text] [Related]
11. [Safety of monoclonal antibody anti-CD 20 in refractory thrombocytopenic idiopathic purpura].
de Roux Serratrice C; Brandi Y; Caillères S; Brunel V; Allègre T; Blanc AP
Rev Med Interne; 2002 Oct; 23(10):869-70. PubMed ID: 12428493
[No Abstract] [Full Text] [Related]
12. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.
Giagounidis AA; Anhuf J; Schneider P; Germing U; Söhngen D; Quabeck K; Aul C
Eur J Haematol; 2002 Aug; 69(2):95-100. PubMed ID: 12366712
[TBL] [Abstract][Full Text] [Related]
13. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
Aggarwal A; Catlett JP
South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab).
Ibrahim K; Maghfoor I; Elghazaly A; Bakshi N; Mohamed SY; Aljurf M
Hematol Oncol Stem Cell Ther; 2011; 4(2):100-2. PubMed ID: 21727772
[TBL] [Abstract][Full Text] [Related]
15. Clinical remission following monoclonal anti-CD20 therapy in two children with chronic refractory idiopathic thrombocytopenic purpura.
Moschovi M; Trimis G; Pergantou H; Platokouki H; Vrachnou E; Tzortzatou-Stathopoulou F
J Paediatr Child Health; 2005 Jul; 41(7):384-6. PubMed ID: 16014149
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus.
Lee JW; Kim HA; Sung JM; Suh CH
Lupus; 2010 Feb; 19(2):227-8. PubMed ID: 19884220
[No Abstract] [Full Text] [Related]
17. Rituximab: a new therapeutic tool for primary immune thrombocytopenic purpura?
Introna M; Golay J; Barbui T
Haematologica; 2003 May; 88(5):482-4. PubMed ID: 12745265
[No Abstract] [Full Text] [Related]
18. Chronic refractory idiopathic thrombocytopenic purpura (ITP) and anti-CD20 monoclonal antibody: a case report.
Latifzadeh SZ; Entezari V
Clin Appl Thromb Hemost; 2006 Oct; 12(4):489-92. PubMed ID: 17000895
[TBL] [Abstract][Full Text] [Related]
19. [Good response to treatment with rituximab in a child with refractory idiopathic thrombocytopenic purpura].
Fríguls-Francitorra B; Almazán-Castro F; Manchón GJ
Med Clin (Barc); 2006 Sep; 127(12):478-9. PubMed ID: 17040639
[No Abstract] [Full Text] [Related]
20. Effective B cell depletion with rituximab in the treatment of autoimmune diseases.
Kneitz C; Wilhelm M; Tony HP
Immunobiology; 2002 Dec; 206(5):519-27. PubMed ID: 12607727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
